PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.16%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.91%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
133.15%
EBIT growth 50-75% of NXPI's 248.48%. Martin Whitman would suspect suboptimal resource allocation.
184.17%
Operating income growth at 50-75% of NXPI's 248.48%. Martin Whitman would doubt the firm’s ability to compete efficiently.
37.12%
Net income growth under 50% of NXPI's 87.93%. Michael Burry would suspect the firm is falling well behind a key competitor.
39.13%
EPS growth under 50% of NXPI's 88.06%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
39.13%
Diluted EPS growth under 50% of NXPI's 88.06%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.54%
Share reduction while NXPI is at 0.47%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.09%
Reduced diluted shares while NXPI is at 0.47%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.74%
Dividend reduction while NXPI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-66.82%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-72.09%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
98.72%
10Y revenue/share CAGR above 1.5x NXPI's 33.25%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
5.70%
5Y revenue/share CAGR under 50% of NXPI's 33.25%. Michael Burry would suspect a significant competitive gap or product weakness.
0.26%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
177.32%
10Y OCF/share CAGR 1.25-1.5x NXPI's 127.88%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
-32.68%
Negative 5Y OCF/share CAGR while NXPI is at 127.88%. Joel Greenblatt would question the firm’s operational model or cost structure.
-43.52%
Negative 3Y OCF/share CAGR while NXPI stands at 783.97%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
367.16%
Net income/share CAGR above 1.5x NXPI's 97.92% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-34.45%
Negative 5Y net income/share CAGR while NXPI is 97.92%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-38.72%
Negative 3Y CAGR while NXPI is 96.50%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
54.13%
Equity/share CAGR of 54.13% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
33.19%
Equity/share CAGR of 33.19% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
24.41%
3Y equity/share CAGR at 50-75% of NXPI's 44.44%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
846.73%
Dividend/share CAGR of 846.73% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
109.10%
Dividend/share CAGR of 109.10% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
73.43%
3Y dividend/share CAGR of 73.43% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
8.37%
AR growth well above NXPI's 11.55%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.24%
Inventory is declining while NXPI stands at 2.10%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.81%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.46%
Positive BV/share change while NXPI is negative. John Neff sees a clear edge over a competitor losing equity.
-0.05%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-1.41%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
6.74%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.